MTOR and acute lymphoblastic leukemia: Based on our observations, hyperactivation of AKT/mTOR signaling promotes the KRAS-G12D mutation-induced rewiring of amino acid metabolism, which compromises the growth of B-ALL cells; this conclusion is supported by our evidence showing that chemically inhibiting mTOR rescued the growth defects of RASmt cells in vivo.